1-204944400-A-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 3P and 8B. PM2PP2BP4_ModerateBP6_ModerateBS1
The NM_001005388.3(NFASC):āc.85A>Gā(p.Met29Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000125 in 1,361,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001005388.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFASC | NM_001005388.3 | c.85A>G | p.Met29Val | missense_variant | 3/30 | ENST00000339876.11 | NP_001005388.2 | |
NFASC | NM_001160331.2 | c.85A>G | p.Met29Val | missense_variant | 2/28 | ENST00000539706.6 | NP_001153803.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NFASC | ENST00000339876.11 | c.85A>G | p.Met29Val | missense_variant | 3/30 | 5 | NM_001005388.3 | ENSP00000344786 | ||
NFASC | ENST00000539706.6 | c.85A>G | p.Met29Val | missense_variant | 2/28 | 5 | NM_001160331.2 | ENSP00000438614 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000710 AC: 1AN: 140928Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000498 AC: 12AN: 241080Hom.: 0 AF XY: 0.0000764 AC XY: 10AN XY: 130818
GnomAD4 exome AF: 0.0000131 AC: 16AN: 1220260Hom.: 0 Cov.: 32 AF XY: 0.0000182 AC XY: 11AN XY: 603282
GnomAD4 genome AF: 0.00000710 AC: 1AN: 140928Hom.: 0 Cov.: 32 AF XY: 0.0000147 AC XY: 1AN XY: 68192
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at